672 reports of this reaction
1.3% of all GUSELKUMAB reports
#18 most reported adverse reaction
UNDERDOSE is the #18 most commonly reported adverse reaction for GUSELKUMAB, manufactured by Janssen Biotech, Inc.. There are 672 FDA adverse event reports linking GUSELKUMAB to UNDERDOSE. This represents approximately 1.3% of all 50,420 adverse event reports for this drug.
Patients taking GUSELKUMAB who experience underdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
UNDERDOSE is a less commonly reported adverse event for GUSELKUMAB, but still significant enough to appear in the safety profile.
In addition to underdose, the following adverse reactions have been reported for GUSELKUMAB:
The following drugs have also been linked to underdose in FDA adverse event reports:
UNDERDOSE has been reported as an adverse event in 672 FDA reports for GUSELKUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
UNDERDOSE accounts for approximately 1.3% of all adverse event reports for GUSELKUMAB, making it a notable side effect.
If you experience underdose while taking GUSELKUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.